ACIâ„¢-NC Program Schedule
Friday, October 3, 2014
8:00 am - 3:30 pm
Carolina Ballroom A & C
Sheraton Charlotte Hotel
555 S. McDowell St
Charlotte, North Carolina 28204
Program Schedule
Presentations included allotted time for Audience Response System (ARS) assisted audience
interaction as well as general question and answer time.
| 7:00 am - 8:00 am | Registration |
| 7:00 am - 8:00 am | Continental Breakfast |
| 8:00 am - 8:10 am | Welcome and Overview Asim Amin, MD, PhD – Levine Cancer Institute Carolinas Medical Center and John D. Powderly II, MD, CPI – Carolina BioOncology Institute, PLLC |
| Session I: Basic Principles of Tumor Immunology and Immunotherapy 2.25 AMA PRA Category 1 Credits™ |
|
| 8:10 am - 8:40 am | Immune Effector Mechanisms: B and T Cell Immunology Laszlo G. Radvanyi, PhD – Moffitt Cancer Center |
| 8:40 am - 9:10 am | Antigen Presentation  John H. Stewart IV, MD, MBA, FACS – Wake Forest University School of Medicine |
| 9:10 am - 9:40 am | Modulation of the Immune Response Brent A. Hanks, MD, PhD – Duke University Medical Center |
| 9:40 am - 10:10 am | Principles of Immunotherapy H. Kim Lyerly, MD – Duke University Medical Center |
| 10:10 am - 10:20 am | Panel Discussion |
| 10:20 am - 10:35 am | Break |
| Session II: Checkpoint Blockade-Based Immunotherapy 1.75 AMA PRA Category 1 Credits™ |
|
| 10:35 am - 11:15 am | CTLA-4 Blockade: Indications and Clinical Management Asim Amin, MD, PhD – Levine Cancer Institute Carolinas Medical Center |
| 11:15 am - 11:55 am | PD-1 Inhibition John D. Powderly II, MD, CPI – Carolina BioOncology Institute, PLLC |
| 11:55 am - 12:15 pm | Panel Discussion |
| 12:15 pm - 1:00 pm | Lunch |
| Session III: Non-Checkpoint Blockade-Based Immunotherapy 2.5 AMA PRA Category 1 Credits™ |
|
| 1:00 pm - 1:30 pm | Cytokines (IL-2 and IFN): Indications and Clinical Management Richard L. White, Jr., MD, FACS – Levine Cancer Institute Carolinas Medical Center |
| 1:30 pm - 2:00 pm | Adoptive T Cell Therapy with Variations Rodabe N. Amaria, MD – University of Texas, MD Anderson Cancer Center |
| 2:00 pm - 2:30 pm | Vaccines Michael A. Morse, MD, MHS – Duke University Medical Center |
| 2:30 pm - 3:00 pm | Vaccine Adjuvants Craig L. Slingluff, Jr., MD – University of Virginia |
| 3:00 pm - 3:20 pm | Panel Discussion |
| 3:20 pm - 3:30 pm | Closing Remarks Asim Amin, MD, PhD – Levine Cancer Institute Carolinas Medical Center and John D. Powderly II, MD, CPI – Carolina BioOncology Institute, PLLC |
